SarGini Bio’s R&D division is engaged in developing niche Biopharmaceutical products for human healthcare industries for example Biologics and Molecular Diagnostics industries

Our product & services also cater to other industries for example CROs, Gene & Cell therapy programs, Hematologic Disorders management, companies providing drug discovery solutions and regulatory compliance.

• Focus on developing invasive/non-invasive diagnostics for early detection of cancer for global market
• Develop Proprietary Technology platform of Tumour Markers, Diagnostic Assays, Algorithms
• Carry out POC studies demonstrating biomarkers as highly sensitive and specific for detecting people with and without cancer
• Further Develop, Optimise & Validate the TESTS

• Create a Pipeline of High Value Diagnostics and Therapeutics at research-stage for multiple cancers